# Bioceres Crop (BIOX) — Earnings

BIOX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/biox/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.39 |
| EPS estimate | −$0.06 |
| EPS surprise | −542.00% |
| Revenue surprise | −29.24% |
| Revenue | $55.9M |
| Revenue estimate | $79.0M |
| Reported | Sep 16, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1769484/000110465926108004/tm2625463d1_6k.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/b119a6bf-1678-40c9-3382-4881631d92c2.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2026 | Sep 16, 2026 | −$0.06 | −$0.39 | -542.00% | $79.0M | $55.9M |
| Q3 2026 | May 12, 2026 | −$0.05 | −$0.16 | -214.40% | $54.5M | $39.4M |
| Q1 2026 | Nov 13, 2025 | −$0.06 | −$0.12 | -86.89% | $94.6M | $77.5M |
| Q4 2025 | Sep 9, 2025 | $0.07 | −$0.70 | -1138.37% | $110.1M | $74.7M |
| Q3 2025 | May 21, 2025 | −$0.13 | −$0.02 | 83.44% | $63.0M | $60.6M |
| Q2 2025 | Feb 12, 2025 | $0.10 | $0.01 | -90.26% | $123.9M | $106.7M |
| Q1 2025 | Nov 12, 2024 | −$0.02 | −$0.08 | -283.18% | $110.0M | $93.3M |
| Q4 2024 | Sep 10, 2024 | $0.23 | −$0.03 | -114.06% | $134.2M | $124.0M |
| Q3 2024 | May 14, 2024 | $0.17 | $0.14 | -18.12% | $98.5M | $84.0M |
| Q2 2024 | Feb 9, 2024 | $0.09 | $0.02 | -79.57% | $117.0M | $140.2M |
| Q1 2024 | Nov 14, 2023 | $0.09 | −$0.07 | -177.78% | $123.8M | $116.6M |
| Q4 2023 | Sep 11, 2023 | $0.02 | −$0.06 | -400.50% | $105.0M | $104.7M |
| Q3 2023 | May 11, 2023 | −$0.03 | $0.44 | 1775.38% | $88.4M | $93.6M |
| Q2 2023 | Feb 9, 2023 | $0.07 | −$0.13 | -285.71% | $92.0M | $94.4M |
| Q1 2023 | Nov 14, 2022 | $0.05 | $0.04 | -27.08% | $82.0M | $127.1M |
| Q4 2022 | Sep 8, 2022 | $0.20 | −$0.12 | -160.36% | $94.9M | $105.7M |
| Q3 2022 | May 12, 2022 | −$0.08 | −$0.16 | -104.08% | $44.6M | $69.5M |
| Q2 2022 | Feb 10, 2022 | $0.18 | $0.08 | -56.59% | $70.0M | $92.7M |
| Q1 2022 | Nov 10, 2021 | $0.09 | $0.02 | -77.27% | $52.6M | $66.9M |
| Q4 2021 | Sep 30, 2021 | $0.19 | $0.02 | -89.58% | $53.9M | $82.2M |

## Frequently Asked Questions

### When did Bioceres Crop (BIOX) last report earnings?

Bioceres Crop last reported on Sep 16, 2026, covering fiscal Q4 2026.

### Did BIOX beat earnings estimates?

No. Bioceres Crop reported EPS of −$0.39 for Q4 2026 against a −$0.06 estimate — a 542.00% miss.

### How much revenue did BIOX report last quarter?

Bioceres Crop reported $55.9M in revenue for Q4 2026, against a consensus estimate of $79.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).